X @Bloomberg

Stock Performance - Eli Lilly and Novo Nordisk shares increased following reports of potential deals with the White House [1] Policy & Regulation - The White House is reportedly negotiating deals with Eli Lilly and Novo Nordisk to lower weight-loss drug prices [1] - The deals are reportedly in exchange for Medicare coverage of these drugs [1]